Coronavirus disease 2019 and cardiovascular diseases: collateral damage?

Pillai, Ajay; Lawson, Barbara D.

doi:10.1097/aco.0000000000001076

Cited by 7 publications

(9 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We cannot forget about the need to vaccinate against COVID-19, which can negatively affect the circulatory system. The complications of COVID-19 may include exacerbation of chronic heart failure or the development of cardiomyopathy or myocarditis and venous thromboembolism [ 45 ]. The ESC guidelines confirm that patients with myocardial diseases should be vaccinated against SARS-CoV-2 [ 46 ].…”

Section: Discussionmentioning

confidence: 99%

Knowledge of Silesia adult inhabitants regarding preventive vaccinations effect on cardiovascular diseases

Dąbek

Sierka

2022

BMC Public Health

View full text Add to dashboard Cite

Objectives Protective vaccinations are important in maintaining health and reducing suffering from infectious diseases. Also, vaccine-preventable infectious diseases are associated with the development and progression of cardiovascular diseases. Aim The study aimed to test adults' knowledge of the role of protective vaccinations in the prevention of cardiovascular diseases, and their opinions on the quantity of the information provided by doctors in this regard. Methods A total of 700 adults participated in the study, most of whom were women (500; 71.43%). The study used an original questionnaire containing questions covering vaccinations and cardiovascular diseases, and the general characteristics of the participants. The inclusion criteria for the study were 18 years of age and written informed consent to participate in the study. Results Over 60% of the participants did not know of, or denied the possibility of, developing cardiovascular diseases as a result of avoiding required preventive vaccinations. More than half of the participants stated that there is no need to recommend influenza vaccination to patients with cardiovascular diseases. Over 70% of participants stated that family doctors did not provide sufficient information about protective vaccinations. Conclusion In these adults, knowledge of the role of preventive vaccinations in the prevention of cardiovascular diseases was low, and the quantity of the information provided by doctors about preventive vaccinations were considered to be insufficient. Public awareness of the effects of avoiding preventive vaccinations should be raised especially among people with CVD.

show abstract

Section: Discussionmentioning

confidence: 99%

Knowledge of Silesia adult inhabitants regarding preventive vaccinations effect on cardiovascular diseases

Dąbek

Sierka

2022

BMC Public Health

View full text Add to dashboard Cite

show abstract

“…Patients with SARS-CoV-2 infection and pre-existing HF are more likely to be critically ill, with increased rates of ICU admission, renal replacement therapy, and mechanical ventilation[ 69 ]. Pre-existing HF represented an independent risk factor for mortality during COVID-19 hospitalization, with an adjusted odds ratio of 1.88 (95% confidence interval: 1.27-2.78)[ 70 ].…”

Section: Chronic Heart Failurementioning

confidence: 99%

“…COVID-19 may cause or worsen HF through multiple mechanisms including myocardial ischemia or infarction, activation of the sympathetic nervous system, neurohormonal activation precipitating volume retention, elevations in pulmonary pressures, myocarditis, pulmonary embolism, stress cardiomyopathy, and inflammation leading to myocardial depression. The above mentioned mechanisms play a pivotal role and may subsequently lead to arrhythmias, cardiogenic shock, and/or sudden cardiac death[ 69 , 18 ].…”

Section: Chronic Heart Failurementioning

confidence: 99%

Cardiovascular disease and COVID-19, a deadly combination: A review about direct and indirect impact of a pandemic

Vidal-Pérez¹,

Brandão²,

Pazderník³

et al. 2022

WJCC

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is known to present with respiratory symptoms, which can lead to severe pneumonia and respiratory failure. However, it can have multisystem complications such as cardiovascular manifestations. The cardiovascular manifestations reported comprise myocarditis, cardiogenic shock, arrhythmias, pulmonary embolism, deep vein embolism, acute heart failure, and myocardial infarction. There is also an indirect impact of the pandemic on the management of cardiovascular care that has been shown clearly in multiple publications. In this review, we summarize the deadly relation of COVID-19 with cardiovascular events and the wider impact on several cardiovascular care areas by the pandemic situation

show abstract

“…[1] On the medical front, complications of this viral infection have included reports of isolated infl ammation of the pericardium, pleura and peritoneum. [2][3][4] The medical community has also focused on the persistent symptoms identifi ed after resolution of acute COVID-19. These symptoms have been called by diff erent names: post-COVID conditions, long COVID, and post-acute COVID syndrome.…”

Section: Introductionmentioning

confidence: 99%

Polyserositis as a Post–Covid-19 Complication

Hernández-Perera

Piñeiro-Pérez²,

Martínez-Muñiz³

et al. 2022

MEDICC Review

View full text Add to dashboard Cite

INTRODUCTIONPolyserositis is described as infl ammation with eff usion of more than one serous membrane. There is very little published literature linking it to COVID-19 as a late complication.OBJECTIVE Present and describe a case of post-COVID-19 polyserositis.METHODS Data were collected from the medical record of a female patient admitted for fainting spells and marked weakness. The patient underwent a clinical evaluation, additional hematology, imaging and histopathology tests, and a surgical procedure. RESULTSWe present the case of a 57-year-old female patient admitted to hospital for fainting spells and marked weakness, four months after COVID-19 infection. She also had a history of obesity, asthma, type 2 diabetes mellitus and a cholecystectomy in December 1992 for gallstones. Clinical assessment revealed pericardial eff usion and bilateral pleural eff usion, in addition to a tumor-like lesion outside the pericardium, proximal to the right ventricular wall. A surgical procedure and fi ndings from additional tests led to diagnoses of thymic remnants and polyserositis.CONCLUSIONS This is a case of polyserositis in a post-COVID-19 patient. After other causes of polyserositis were ruled out, and since there is a likely physiological and pathogenic mechanism operating between the two diseases, the polyserositis was determined to be a late complication of COVID-19. To date, it is the second case reported in the world and the fi rst reported in Cuba.

show abstract

Coronavirus disease 2019 and cardiovascular diseases: collateral damage?

Cited by 7 publications

References 50 publications

Knowledge of Silesia adult inhabitants regarding preventive vaccinations effect on cardiovascular diseases

Knowledge of Silesia adult inhabitants regarding preventive vaccinations effect on cardiovascular diseases

Cardiovascular disease and COVID-19, a deadly combination: A review about direct and indirect impact of a pandemic

Polyserositis as a Post–Covid-19 Complication

Contact Info

Product

Resources

About